Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
LepRb+ cell–specific deletion of Slug mitigates obesity and nonalcoholic fatty liver disease in mice
Min-Hyun Kim, … , Wen-Shu Wu, Liangyou Rui
Min-Hyun Kim, … , Wen-Shu Wu, Liangyou Rui
Published December 13, 2022
Citation Information: J Clin Invest. 2023;133(4):e156722. https://doi.org/10.1172/JCI156722.
View: Text | PDF
Research Article Cell biology Metabolism Article has an altmetric score of 15

LepRb+ cell–specific deletion of Slug mitigates obesity and nonalcoholic fatty liver disease in mice

  • Text
  • PDF
Abstract

Leptin exerts its biological actions by activating the long-form leptin receptor (LepRb). LepRb signaling impairment and leptin resistance are believed to cause obesity. The transcription factor Slug — also known as Snai2 — recruits epigenetic modifiers and regulates gene expression by an epigenetic mechanism; however, its epigenetic action has not been explored in leptin resistance. Here, we uncover a proobesity function of neuronal Slug. Hypothalamic Slug was upregulated in obese mice. LepRb+ cell–specific Slug-knockout (SlugΔLepRb) mice were resistant to diet-induced obesity, type 2 diabetes, and liver steatosis and experienced decreased food intake and increased fat thermogenesis. Leptin stimulated hypothalamic Stat3 phosphorylation and weight loss to a markedly higher level in SlugΔLepRb than in Slugfl/fl mice, even before their body weight divergence. Conversely, hypothalamic LepRb+ neuron–specific overexpression of Slug, mediated by AAV-hSyn-DIO-Slug transduction, induced leptin resistance, obesity, and metabolic disorders in mice on a chow diet. At the genomic level, Slug bound to and repressed the LepRb promoter, thereby inhibiting LepRb transcription. Consistently, Slug deficiency decreased methylation of LepRb promoter H3K27, a repressive epigenetic mark, and increased LepRb mRNA levels in the hypothalamus. Collectively, these results unravel what we believe to be a previously unrecognized hypothalamic neuronal Slug/epigenetic reprogramming/leptin resistance axis that promotes energy imbalance, obesity, and metabolic disease.

Authors

Min-Hyun Kim, Yuan Li, Qiantao Zheng, Lin Jiang, Martin G. Myers Jr., Wen-Shu Wu, Liangyou Rui

×

Figure 6

Hypothalamic LepRb neuron–specific overexpression of Slug induces obesity.

Options: View larger image (or click on image) Download as PowerPoint
Hypothalamic LepRb neuron–specific overexpression of Slug induces obesit...
(A) AAV-hSyn-DIO-Slug vectors were coinjected with either AAV-CAG-GFP or AAV-CAG-Cre vectors into the brains of C57BL/6J mice. Brain extracts were prepared 3 weeks later and immunoblotted with antibodies against Slug or α-tubulin. (B–H) AAV-hSyn-DIO-Slug or AAV-hSyn-DIO-mCherry vectors were bilaterally microinjected into the MBH of SlugΔLepRb (Slugfl/fl;LepRb-Cre+/+) males (8 weeks, on chow diet). Slugfl/fl males (lacking Cre) were injected with AAV-hSyn-DIO-Slug vectors (control). (B) Hypothalamic extracts were immunoblotted with antibodies against Slug or α-tubulin (12 weeks after AAV transduction). (C) Body weight. (D) Fat content at 12 weeks after AAV transduction (% body weight). (E) Tissue weight (12 weeks after AAV transduction). (F and G) GTT and ITT at 11 weeks after AAV transduction. (H) Liver TAG levels at 12 weeks after AAV transduction (normalized to liver weight). AAV-hSyn-DIO-Slug/ SlugΔLepRb, n = 8; AAV-hSyn-DIO-mCherry/SlugΔLepRb, n = 7; AAV-hSyn-DIO-Slug/Slugfl/fl, n = 4. (I and J) AAV-CAG-DIO-Slug or AAV-CAG-DIO-mCherry vectors were bilaterally microinjected into the MBH of SlugΔLepRb (Slugfl/fl;LepRb-Cre+/–) male mice at 9 weeks of age on chow diet (n = 5 mice per group). (I) Body weight. (J) GTT (2 g glucose/kg) and ITT (1 unit insulin/kg) at 8 weeks after AAV transduction. Data are presented as mean ± SEM. *P < 0.05, 1-way (D and E, F [right panel], G [right panel], and H) and 2-way (C, F [left panel], G [left panel], I, and J) ANOVA.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 27 X users
14 readers on Mendeley
See more details